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83. REDUCING GP ATTENDANCE IN PATIENTS WITH FIBROMYALGIA
Sarah Ryan1, Peter Dawes1, Jon Packham1 and Clinical Auditor2
1Staffordshire Rheumatology Centre, Haywood Hospital, Burslem, Stoke on
Trent, United Kingdom and 2Clinical Audit Department, University Hospital of
North Staffordshire, Stoke on Trent, Staffordshire, United Kingdom
Background: Patients with fibromyalgia are frequent users of health care provision
in both primary and secondary health care settings. In 2004 a retrospective audit of
60 consecutive patients with fibromyalgia, identified a reduction in the utilisation of
hospital based services following attendance at a consultant nurse led pain clinic.
We wondered if this reduction in secondary health provision had led to an increase
in primary care attendance. The aim of this audit was to identify whether the
number of general practitioner appointments for symptoms relating to fibromyalgia,
in this same cohort, had changed in the 12 month period before and after atten-
dance at the nurse consultant led pain clinic.
Methods: The 60 patients were attending 23 GP practices within North
Staffordshire. The GP practices were contacted and granted access for a clinical
auditor to review patients’ records to determine the number of attendances for
fibromyalgia related symptoms. For each GP visit the main reason for attendance
was noted and grouped into one of the following categories; musculoskeletal pain,
mood and somatisation involving other organ systems including chest pain.
Results: The sample consisted of 57 women and 3 men, mean age of 41 years
(range 29–71). Forty two patients were married and 22 were in employment.
49/60 (82%) patients’ GP records was reviewed. 11/60 patients’ records were not
included due to having left the practice (4) or having no retrievable information from
the records for the dates required (7).
Over the 2 year period of data collection, 49 patients had a total of 295 consul-
tations with a GP. One hundred and ninety six (66%) consultations were in the
12 months prior to the date of the nurse led pain clinic and 99 (33%) occurred in
the 12 months after clinic attendance.
38/49 (78%) patients reduced their visits to their GP for the 12 months following
pain clinic attendance, 8 patients (6%) increased their visits and 3 (6%) patients’
consultation habits remained unchanged.
The main areas where a reduction in consultation had occurred were pain,
where 57.2% fewer attendances occurred, and mood with 56.5% fewer atten-
dances recorded. Not surprisingly the impact of the pain clinic upon non musculo-
skeletal symptoms was less marked with a reduction of just 22%.
Conclusions: A designated community based service for patients with fibro-
myalgia can reduce the utilisation of both primary and secondary care services.
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Background: Juvenile idiopathic arthritis runs an unpredictable course. Children
with oligoarticular disease may respond well to intra-articular steroids or have
recurrent episodes of synovitis. Children with polyarticular disease may respond to
Methotrexate or require steroids and/or biologics. Currently there are no reliable
predictors of outcome in early disease, which leads to sub-optimal treatment.
Methods: We are currently undertaking a five-year prospective study of children
with newly diagnosed and untreated JIA. All have knee involvement. At outset,
we obtain synovial biopsies (N¼ 5) under ultrasound guidance. We then record
detailed clinical, functional, radiological and laboratory data every 3/12 for two
years. We are correlating outcomes at one and two years with synovial findings
recorded at outset. Here we report on those children whom to date we have
followed for one year.
Results: Of the first 30 children, 18 had oligoarticular disease. Their disease
activity score fell from a mean of 3.54 to 1.12 at one year. Ten had a single episode
of swelling of the index joint while eight had 2 or more episodes.
Twelve had polyarticular disease. All but two were improved at one year.
The mean ESR fell from 44 to 13, and CRP from 33 to 5. Haemoglobin rose from
a mean of 10.6 mg/dl to 12.5 mg/dl. The CHAQ improved in all but two.
We found significantly more synovial pathology in the poly compared with oligo
patients, with mean vessel score 6.9 vs. 2.6 (p< 0.05) and mean B-cell score
1.7 vs. 1.0 (p<0.05).
On average, the oligo and polyarticular groups shared a similar degree of
synovial hyperplasia and a comparable macrophage distribution. The CD3þ cells
(mean 1.7 (0.8–2.7)) were predominately CD4þ (mean 1.7 (0.7–2.6)) and
distributed mainly within the sub-lining layer (SLL).
However, we observed significant differences between patients within clinical
subgroups.
Conclusions: Almost 50% of oligoarticular patients had recurrent knee swelling,
despite treatment. And while the majority of poly JIA responded to Methotrexate,
a significant minority still required steroids or were already on biologics at one year.
Infiltrates varied widely between patients; and we predict that synovial pathology,
particularly vascularity and B-cell infiltrates, will correlate with a poor outcome and
inadequate response to treatment.
We will therefore analyse whether synovial findings can predict outcome for
each patient.
Disclosure: The authors have declared no conflicts of interest.
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Background: There is controversy regarding the frequency of anti-CCP antibody
positivity in JIA. Previous studies have shown variability of anti-CCP antibody
prevalence according to JIA subtype, with Rheumatoid factor positive patients
having a higher prevalence. It is generally accepted that routine testing of JIA
patients for diagnostic or prognostic purposes holds little value. However, one study
using a synthetic peptide as an antigen showed the prevalence of anti-CCP in JIA
to be significantly greater (77% positivity reported in 51/66 JIA). The aim of this
study is to assess anti-CCP positivity in children with JIA using the synthetic peptide
and two commercial ELISA kits (CCP2, CCP3).
Methods: Serum samples were collected from JIA patients in a paediatric
rheumatology out-patient setting (n¼43) and non-JIA juvenile controls (n¼ 26).
IgG anti-CCP was measured using ELISA technique on a synthetic peptide
(cfc-1-cyc Invitrogen), commercial anti-CCP2 (Axis-Shield) and CCP3 (Inova).
Results: The positivity rate using the synthetic peptide (14%) was comparable to
the commercial kits (CCP2 16%) or (CCP3 12%). Combining all three assays
resulted in an overall positivity of 23%. Only 2 samples tested positive in all three
assays. Generally, polyarticular JIA patients showed a higher prevalence of anti-
CCP. Using the CCP2 kit, 4 out of 16 polyarticular JIA patients (25%) and 1 out
of 19 oligoarticular JIA patients (5%) tested positive. Using a combination of the
assays, none of the 26 non-JIA controls tested positive.
Conclusions: Our study confirms the presence of Anti-CCP antibodies in JIA
patients. Although the overall prevalence is low, it is slightly higher than reported in
recent studies. In concordance with previous studies, polyarticular disease tends to
yield the highest positivity rate among the JIA subtypes. The presence of positive
controls may be due to patient selection.
We did not find an increase in the detection rate of anti-CCP with the synthetic
peptide compared to the commercial kits. The finding of only two JIAs testing
positive for anti-CCP in all three kits highlighted the variability between them.
Whether a JIA patient is anti-CCP antibody positive or not depends on the assay
used. Therefore it seems that no single kit will detect all anti-CCP antibodies in JIA
patients who are positive. The implication here is that in JIA there may be more
antigenic diversity in the anti-CCP response compared to adult Rheumatoid
Arthritis. This suggests that to increase the detection rate, either assay kits can be
used in combination, or a more appropriate antigen developed.
Disclosure: The authors have declared no conflicts of interest.
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Background: Juvenile Idiopathic Arthritis (JIA) is the most common rheumatic
disease in children. There are various subtypes of JIA, with major differences in
both severity and outcome. Both T cells and Dendritic Cells (DC) are key cell types
contributing to the pathology of JIA. We have found CD4þCD25þ regulatory T cells
(Treg) in the synovial fluid (SF) of children with JIA, and DC in a semi-mature state
in SF. Using a method previously developed in our laboratory to generate tolero-
genic dendritic cells from healthy PBMC, we have adapted it to generate tolero-
genic dendritic cells from synovial cells of children with arthritis and we have
investigated the ability of T cells from the joint to be suppressed.
Methods: Human monocyte derived DC grown from SF from children with JIA,
were infected with replication deficient adenoviral (rAd) constructs (E1-E3-deleted)
and then matured. CFSE- labelled T cells were cultured with either autologous DC
(adenoviral infected or control) and stimulated with PHA, or were seeded with
allogeneic DC. T cell proliferation was measured by CFSE dilution using flow
cytometry.
 at Queens University of Belfast on December 19, 2012
http://rheum
atology.oxfordjournals.org/
D
ow
nloaded from
 
